Evaluation of gonadotropin-releasing hormone agonist and antagonist protocols on pregnancy outcomes in POSEIDON groups 3 and 4: A randomized controlled trial
Background: Women with low ovarian reserve are the capable part of people who refer to infertility centers, this study compares 2 treatment protocols in cases with low ovarian reserve. Objective: This study aimed to compare the efficacy of gonadotropin-releasing hormone (GnRH) agonist and GnRH-a...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shahid Sadoughi University of Medical Sciences
2025-05-01
|
| Series: | International Journal of Reproductive BioMedicine |
| Subjects: | |
| Online Access: | https://knepublishing.com/index.php/ijrm/article/view/18775 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849688180713848832 |
|---|---|
| author | Zahra Aminimajomerd Maryam Eftekhar Nooshin Hatamizadeh Shahrzad Moeinaddini |
| author_facet | Zahra Aminimajomerd Maryam Eftekhar Nooshin Hatamizadeh Shahrzad Moeinaddini |
| author_sort | Zahra Aminimajomerd |
| collection | DOAJ |
| description |
Background: Women with low ovarian reserve are the capable part of people who refer to infertility centers, this study compares 2 treatment protocols in cases with low ovarian reserve.
Objective: This study aimed to compare the efficacy of gonadotropin-releasing hormone (GnRH) agonist and GnRH-antagonist protocols in women with diminished ovarian reserve (DOR) in POSEIDON groups 3–4 undergoing in assisted reproductive technology (ART).
Materials and Methods: This randomized clinical trial enrolled 158 infertile women with diminished ovarian reserve undergoing ART at the Research and Clinical Center for Infertility, Yazd, Iran from January to October 2024. Women were randomly assigned to either a GnRH-antagonist (n = 84) or a long GnRH-agonist (n = 74). Primary outcomes included clinical pregnancy and secondary outcomes were chemical pregnancy, early abortion rate, ongoing pregnancy, and implantation rate.
Results: No significant differences were observed in baseline values between groups. The GnRH-agonist group had a longer stimulation duration (12.23 vs. 10.60 days, p < 0.001) and a higher total gonadotropin dose (4588.84 vs. 3225.67 IU, p < 0.001) compared to the antagonist group. Clinical pregnancy rates (17.8% vs. 15.8%, p = 0.810) and live birth rates (11.1% vs. 13.2%, p = 0.775) were comparable between the agonist and antagonist groups.
Conclusion: According to acquired data, the GnRH-antagonist and long GnRH-agonist protocols resulted in similar ART outcomes. The antagonist protocol was associated with shorter stimulation and lower gonadotropin consumption. As a result, the antagonist protocol was found to be more cost effective. Larger studies are needed to confirm these results and determine the optimal protocol for this woman group.
|
| format | Article |
| id | doaj-art-ce3505f0f89f436b8dd79feb12ed6e82 |
| institution | DOAJ |
| issn | 2476-4108 2476-3772 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Shahid Sadoughi University of Medical Sciences |
| record_format | Article |
| series | International Journal of Reproductive BioMedicine |
| spelling | doaj-art-ce3505f0f89f436b8dd79feb12ed6e822025-08-20T03:22:04ZengShahid Sadoughi University of Medical SciencesInternational Journal of Reproductive BioMedicine2476-41082476-37722025-05-0123310.18502/ijrm.v23i3.18775Evaluation of gonadotropin-releasing hormone agonist and antagonist protocols on pregnancy outcomes in POSEIDON groups 3 and 4: A randomized controlled trialZahra Aminimajomerd0Maryam Eftekhar1Nooshin Hatamizadeh2Shahrzad Moeinaddini3Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, YazdResearch and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, YazdResearch and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.Research and Clinical Center for Infertility Background: Women with low ovarian reserve are the capable part of people who refer to infertility centers, this study compares 2 treatment protocols in cases with low ovarian reserve. Objective: This study aimed to compare the efficacy of gonadotropin-releasing hormone (GnRH) agonist and GnRH-antagonist protocols in women with diminished ovarian reserve (DOR) in POSEIDON groups 3–4 undergoing in assisted reproductive technology (ART). Materials and Methods: This randomized clinical trial enrolled 158 infertile women with diminished ovarian reserve undergoing ART at the Research and Clinical Center for Infertility, Yazd, Iran from January to October 2024. Women were randomly assigned to either a GnRH-antagonist (n = 84) or a long GnRH-agonist (n = 74). Primary outcomes included clinical pregnancy and secondary outcomes were chemical pregnancy, early abortion rate, ongoing pregnancy, and implantation rate. Results: No significant differences were observed in baseline values between groups. The GnRH-agonist group had a longer stimulation duration (12.23 vs. 10.60 days, p < 0.001) and a higher total gonadotropin dose (4588.84 vs. 3225.67 IU, p < 0.001) compared to the antagonist group. Clinical pregnancy rates (17.8% vs. 15.8%, p = 0.810) and live birth rates (11.1% vs. 13.2%, p = 0.775) were comparable between the agonist and antagonist groups. Conclusion: According to acquired data, the GnRH-antagonist and long GnRH-agonist protocols resulted in similar ART outcomes. The antagonist protocol was associated with shorter stimulation and lower gonadotropin consumption. As a result, the antagonist protocol was found to be more cost effective. Larger studies are needed to confirm these results and determine the optimal protocol for this woman group. https://knepublishing.com/index.php/ijrm/article/view/18775Ovarian reserveOvarian stimulationIn vitro fertilizationART |
| spellingShingle | Zahra Aminimajomerd Maryam Eftekhar Nooshin Hatamizadeh Shahrzad Moeinaddini Evaluation of gonadotropin-releasing hormone agonist and antagonist protocols on pregnancy outcomes in POSEIDON groups 3 and 4: A randomized controlled trial International Journal of Reproductive BioMedicine Ovarian reserve Ovarian stimulation In vitro fertilization ART |
| title | Evaluation of gonadotropin-releasing hormone agonist and antagonist protocols on pregnancy outcomes in POSEIDON groups 3 and 4: A randomized controlled trial |
| title_full | Evaluation of gonadotropin-releasing hormone agonist and antagonist protocols on pregnancy outcomes in POSEIDON groups 3 and 4: A randomized controlled trial |
| title_fullStr | Evaluation of gonadotropin-releasing hormone agonist and antagonist protocols on pregnancy outcomes in POSEIDON groups 3 and 4: A randomized controlled trial |
| title_full_unstemmed | Evaluation of gonadotropin-releasing hormone agonist and antagonist protocols on pregnancy outcomes in POSEIDON groups 3 and 4: A randomized controlled trial |
| title_short | Evaluation of gonadotropin-releasing hormone agonist and antagonist protocols on pregnancy outcomes in POSEIDON groups 3 and 4: A randomized controlled trial |
| title_sort | evaluation of gonadotropin releasing hormone agonist and antagonist protocols on pregnancy outcomes in poseidon groups 3 and 4 a randomized controlled trial |
| topic | Ovarian reserve Ovarian stimulation In vitro fertilization ART |
| url | https://knepublishing.com/index.php/ijrm/article/view/18775 |
| work_keys_str_mv | AT zahraaminimajomerd evaluationofgonadotropinreleasinghormoneagonistandantagonistprotocolsonpregnancyoutcomesinposeidongroups3and4arandomizedcontrolledtrial AT maryameftekhar evaluationofgonadotropinreleasinghormoneagonistandantagonistprotocolsonpregnancyoutcomesinposeidongroups3and4arandomizedcontrolledtrial AT nooshinhatamizadeh evaluationofgonadotropinreleasinghormoneagonistandantagonistprotocolsonpregnancyoutcomesinposeidongroups3and4arandomizedcontrolledtrial AT shahrzadmoeinaddini evaluationofgonadotropinreleasinghormoneagonistandantagonistprotocolsonpregnancyoutcomesinposeidongroups3and4arandomizedcontrolledtrial |